Slogan: Bringing personalized healthcare to the forefront of oncology with advanced diagnostics and tailored tumor profiling for improved patient outcomes.
Description: Helomics® is a thorough personalized healthcare company, advancing the field of oncology with the next generation of diagnostics. The company focuses on enhancing patient outcomes by offering a detailed tumor profile through a unique set of laboratory platforms. These platforms utilize both tissue-based live and fixed cellular analysis, empowering physicians to assess malignant tumors on an individual level. Helomics’ innovative molecular and cellular markers, along with their bioinformatics services, support treatment decisions by delivering crucial information tailored to the specific biological processes of each person's cancer.
Founded: 1995
Industries: Biotechnology, Health Care, Health and Wellness
Last Investment: Corporate Round investment at 19 December 2017
Last Investment Investors: Skyline Medical Inc.
Helomics is a personalized healthcare company specializing in oncology diagnostics, providing tailored tumor profiling for improved patient outcomes. With a focus on individualized treatment, they offer innovative molecular and cellular markers, along with bioinformatics services to support treatment decisions. The company received a corporate round investment from Skyline Medical Inc. in December 2017, positioning itself to further advance its cutting-edge diagnostics in the field of oncology.
